| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JHEP.2008.11.014 |
| P698 | PubMed publication ID | 19231003 |
| P50 | author | Massimo Roncalli | Q37839163 |
| P2093 | author name string | Luigi Terracciano | |
| Massimo Colombo | |||
| Angelo Sangiovanni | |||
| Emanuela Morenghi | |||
| Ja June Jang | |||
| Jae Yeon Seok | |||
| Annarita Destro | |||
| Luca Di Tommaso | |||
| Young Nyun Park | |||
| So Young Jin | |||
| Eunsil Yu | |||
| Massimo Iavarone | |||
| Emanuela Balladore | |||
| P433 | issue | 4 | |
| P304 | page(s) | 746-754 | |
| P577 | publication date | 2008-12-25 | |
| P1433 | published in | Journal of Hepatology | Q15724402 |
| P1476 | title | The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma | |
| P478 | volume | 50 |
| Q33769256 | 14-3-3σ induces heat shock protein 70 expression in hepatocellular carcinoma |
| Q46240327 | A Limited Immunohistochemical Panel Can Subtype Hepatocellular Adenomas for Routine Practice |
| Q85616965 | A case of progressing focal nodular hyperplasia and its molecular expression pattern |
| Q34640456 | A novel panel of biomarkers in distinction of small well-differentiated HCC from dysplastic nodules and outcome values |
| Q84529549 | A serum amyloid A-positive hepatocellular neoplasm arising in alcoholic cirrhosis: a previously unrecognized type of inflammatory hepatocellular tumor |
| Q53196323 | Accuracy and disagreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: role of biopsy. |
| Q37807572 | Adding Value to Liver (and Allograft) Biopsy Evaluation Using a Combination of Multiplex Quantum Dot Immunostaining, High-Resolution Whole-Slide Digital Imaging, and Automated Image Analysis |
| Q26860623 | Alcohol and hepatocellular carcinoma: a review and a point of view |
| Q26795780 | Cell-block procedure in endoscopic ultrasound-guided-fine-needle-aspiration of gastrointestinal solid neoplastic lesions |
| Q58707841 | Changing role of histopathology in the diagnosis and management of hepatocellular carcinoma |
| Q47122200 | Circulating tumor cells as liquid biomarker for high HCC recurrence risk after curative liver resection |
| Q39126282 | Classification and prediction of HCC tissues by Raman imaging with identification of fatty acids as potential lipid biomarkers |
| Q37935712 | Clinical decision making and research in hepatocellular carcinoma: pivotal role of imaging techniques |
| Q35507495 | Clinical values of AFP, GPC3 mRNA in peripheral blood for prediction of hepatocellular carcinoma recurrence following OLT: AFP, GPC3 mRNA for prediction of HCC |
| Q37625957 | Combined use of heat-shock protein 70 and glutamine synthetase is useful in the distinction of typical hepatocellular adenoma from atypical hepatocellular neoplasms and well-differentiated hepatocellular carcinoma. |
| Q50234173 | Concomitant use of heat-shock protein 70, glutamine synthetase and glypican-3 is useful in diagnosis of HBV-related hepatocellular carcinoma with higher specificity and sensitivity. |
| Q37899575 | Contribution of biomarkers and imaging in the management of hepatocellular carcinoma |
| Q26864205 | Current concepts in the immunohistochemical evaluation of liver tumors |
| Q64959827 | Current issues on genomic heterogeneity in hepatocellular carcinoma and its implication in clinical practice. |
| Q50035377 | Development of T cells carrying two complementary chimeric antigen receptors against glypican-3 and asialoglycoprotein receptor 1 for the treatment of hepatocellular carcinoma |
| Q89070708 | Diagnostic Value of Glypican3, Heat Shock Protein 70 and Glutamine Synthetase in Hepatocellular Carcinoma Arising in Cirrhotic and Non-Cirrhotic Livers |
| Q57972656 | Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinoma |
| Q40279432 | Diagnostic delays are common among patients with hepatocellular carcinoma |
| Q36454678 | Discrimination of cirrhotic nodules, dysplastic lesions and hepatocellular carcinoma by their vibrational signature. |
| Q89867713 | Dynamic Changes in Serum Markers and Their Utility in the Early Diagnosis of All Stages of Hepatitis B-Associated Hepatocellular Carcinoma |
| Q42121689 | Early hepatocellular carcinoma |
| Q93020038 | Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study |
| Q36217858 | Enhancer of zeste homologue 2 (EZH2) is a reliable immunohistochemical marker to differentiate malignant and benign hepatic tumors. |
| Q34959601 | Expression level of glutamine synthetase is increased in hepatocellular carcinoma and liver tissue with cirrhosis and chronic hepatitis B. |
| Q37901565 | Fine needle aspiration biopsy of hepatocellular carcinoma and hepatocellular nodular lesions: role, controversies and approach to diagnosis |
| Q35101651 | Fine-needle aspiration biopsy of hepatocellular carcinoma and related hepatocellular nodular lesions in cirrhosis: controversies, challenges, and expectations |
| Q47842185 | From large to small: the immunohistochemical panel in the diagnosis of early hepatocellular carcinoma. |
| Q51357706 | GLUL Promotes Cell Proliferation in Breast Cancer. |
| Q34079695 | Gd-EOB-DTPA-enhanced magnetic resonance imaging and alpha-fetoprotein predict prognosis of early-stage hepatocellular carcinoma |
| Q37046449 | Global proteomic profiling in multistep hepatocarcinogenesis and identification of PARP1 as a novel molecular marker in hepatocellular carcinoma |
| Q37625736 | Glypican-3 antibodies: a new therapeutic target for liver cancer |
| Q90012553 | Glypican-3: A New Target for Diagnosis and Treatment of Hepatocellular Carcinoma |
| Q39378285 | Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment |
| Q26827487 | Glypican-3: a marker and a therapeutic target in hepatocellular carcinoma |
| Q24273349 | Heat shock proteins as danger signals for cancer detection |
| Q38725577 | Heat shock proteins in hepatocellular carcinoma: Molecular mechanism and therapeutic potential |
| Q37832405 | Hepatocarcinogenesis: imaging-pathologic correlation. |
| Q92112841 | Hepatocellular Carcinoma Xenografts Established From Needle Biopsies Preserve the Characteristics of the Originating Tumors |
| Q57756376 | Hepatocellular carcinoma |
| Q36716630 | Hepatocellular carcinoma arising in adenoma: similar immunohistochemical and cytogenetic features in adenoma and hepatocellular carcinoma portions of the tumor. |
| Q36171275 | Hepatocellular carcinoma: natural history, current management, and emerging tools |
| Q103836761 | Hepatocellular carcinoma: old friends and new tricks |
| Q42114895 | Hepatocellular tumors: immunohistochemical analyses for classification and prognostication |
| Q83753619 | Histological diagnosis of early hepatocellular carcinoma |
| Q47855351 | Histological differentiation grade and microvascular invasion of hepatocellular carcinoma predicted by dynamic contrast-enhanced MRI. |
| Q57782429 | Histology/pathology |
| Q64927295 | Histopathologic features of hepatocellular carcinoma. |
| Q53467129 | Histopathological classification of hepatocellular carcinoma. |
| Q34552007 | Histopathology of hepatocellular carcinoma |
| Q39381803 | How to Differentiate Borderline Hepatic Nodules in Hepatocarcinogenesis: Emphasis on Imaging Diagnosis |
| Q42278099 | Hyperplastic hepatocellular nodule with localized hemangiomatosis: A hither-to unrecognized type of hypervascular hepatic lesion |
| Q52373297 | Identification of the Differential Expression Profiles of Serum and Tissue Proteins During Rat Hepatocarcinogenesis. |
| Q90298784 | Immunization with glypican-3 nanovaccine containing TLR7 agonist prevents the development of carcinogen-induced precancerous hepatic lesions to cancer in a murine model |
| Q28649881 | Integration of tumour and viral genomic characterizations in HBV-related hepatocellular carcinomas |
| Q35167968 | Keratin 19 epithelial patterns in cirrhotic stroma parallel hepatocarcinogenesis |
| Q35740127 | Leukemia inhibitory factor receptor is a novel immunomarker in distinction of well-differentiated HCC from dysplastic nodules |
| Q37860680 | Liver precancerous lesions and hepatocellular carcinoma: the histology report. |
| Q28258769 | Management of HCC |
| Q61337229 | Mn-loaded apoferritin: a highly sensitive MRI imaging probe for the detection and characterization of hepatocarcinoma lesions in a transgenic mouse model |
| Q34954493 | Molecular pathology of hepatic neoplasms: classification and clinical significance |
| Q50534138 | Neonatal streptozotocin treatment causes type 1 diabetes and subsequent hepatocellular carcinoma in DIAR mice fed a normal diet. |
| Q58450461 | Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies |
| Q36224975 | Overview of hepatocellular adenoma in Japan |
| Q57782479 | Pathologie hépatique Cirrhose et carcinome hépatocellulaire : indications et rôles de la biopsie hépatique |
| Q37491353 | Positive glypican-3 expression in early hepatocellular carcinoma predicts recurrence after hepatectomy |
| Q64097554 | Promotion of growth factor signaling as a critical function of β-catenin during HCC progression |
| Q57294531 | Proteoglycans Are Attractive Biomarkers and Therapeutic Targets in Hepatocellular Carcinoma |
| Q26772304 | Proteoglycans in liver cancer |
| Q36563432 | Quantitative proteomics and phosphoproteomics on serial tumor biopsies from a sorafenib-treated HCC patient |
| Q37910079 | Radiofrequency ablation of high-grade dysplastic nodules |
| Q30244651 | Screening and surveillance for hepatocellular carcinoma: perspective of a new era? |
| Q53155506 | Sex-determination gene SRY potentially associates with poor prognosis but not sex bias in hepatocellular carcinoma. |
| Q53232555 | Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis. |
| Q38635474 | The biology of Hepatocellular carcinoma: implications for genomic and immune therapies |
| Q84517621 | The new generation of hepatocellular markers |
| Q47151061 | The stromal morphological changes for differential diagnosis of uninodular high-grade dysplastic nodule and well-differentiated small hepatocellular carcinoma |
| Q39172203 | Tissue Biomarkers in Hepatocellular Tumors: Which, When, and How. |
| Q35356022 | Tumor-promoting/progressing role of additional chromosome instability in hepatic carcinogenesis in Sgo1 (Shugoshin 1) haploinsufficient mice |
| Q64116906 | Update on hepatocellular carcinoma: Pathologists' review |
| Q84889580 | [Highly differentiated liver tumors: recent developments and their diagnostic application] |
Search more.